BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Stock Repurchase Program |
| November 15, 2012 | November 2012 Bond Updates |
|
LYNBROOK, N.Y., Nov. 15, 2012 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in Europe and Eurasia, today announced that its Board... |
| View more at: http://www.prnewswire.com/news-releases/biospecifics-technologies-corp-announces-board-authorization-of-up-to-2-million-stock-repurchase-program-179464651.html |
| Related News |